Antibodies Contract Manufacturing Market Size And Forecast For Application Segments Up To 2030
Antibodies Contract Manufacturing Market Growth & Trends The global antibodies contract manufacturing market is expected to reach USD 35.9 billion by 2030, registering a CAGR of 13.1% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rise in demand for the production of therapeutic antibodies is the main factor that will drive the growth of the market during the forecast period. Antibodies are the leading biopharmaceutical products that precisely target abnormal cells. Thus, many biopharmaceutical companies have begun to focus on the development of advanced antibodies for the treatment of chronic diseases such as cancer, arthritis, and rheumatic heart disease. The impact of COVID-19 has boosted the market growth, with the application of monoclonal antibodies therapy used as a treatment for COVID-19 patients. Antibodies Contract Manufacturing Market Segmentation Grand View Research has segmented the global antibodies contract manufact...